Innovative AI Model enhances cardiac amyloidosis diagnosis
Digital Health Global
APRIL 19, 2024
In a significant advancement for cardiac healthcare, The Lancet Digital Health has recently published a commentary article detailing an artificial intelligence (AI)-driven approach to improve the screening for transthyretin (ATTR) cardiac amyloidosis.
Let's personalize your content